Species difference of drug metabolism: difficulty of prediction of drug disposition in human from animal data

[1]  T. Imai,et al.  Evidence for the Involvement of a Pulmonary First-Pass Effect via Carboxylesterase in the Disposition of a Propranolol Ester Derivative after Intravenous Administration , 2003, Journal of Pharmacology and Experimental Therapeutics.

[2]  P. Taylor,et al.  Current progress on esterases: from molecular structure to function. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[3]  A. Horita,et al.  Species Differences in Stereoselective Hydrolase Activity in Intestinal Mucosa , 1998, Pharmaceutical Research.

[4]  T. Imai,et al.  Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. , 1998, Life sciences.

[5]  D. Shen,et al.  Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. , 1997, The Journal of pharmacology and experimental therapeutics.

[6]  T Sakaki,et al.  Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat. , 1996, Biochemical pharmacology.

[7]  U. Christians,et al.  Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine. , 1996, Pharmacology.

[8]  T. Imai,et al.  An In‐vitro and In‐vivo Correlative Approach to the Evaluation of Ester Prodrugs to Improve Oral Delivery of Propranolol , 1993, The Journal of pharmacy and pharmacology.

[9]  N. Hanioka,et al.  Species difference of site-selective glucuronidation of morphine. , 1991, Journal of pharmacobio-dynamics.

[10]  C. von Bahr,et al.  Glucuronidation of codeine and morphine in human liver and kidney microsomes: effect of inhibitors. , 1990, Pharmacology & toxicology.

[11]  Teruko Imai,et al.  Human carboxylesterase isozymes: catalytic properties and rational drug design. , 2006, Drug metabolism and pharmacokinetics.

[12]  Y. Sugiyama,et al.  Species difference in nisoldipine oxidation activity in the small intestine. , 2002, Drug metabolism and pharmacokinetics.

[13]  K. Iwasaki,et al.  Urinary metabolite profile of tiaramide in man and in some animal species. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.